JUAN IGNACIO
ARENAS MIRAVE
Ikertzaileren 2011-2014 tartean
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2015
-
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54
-
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
Liver International, Vol. 35, Núm. 1, pp. 90-100
-
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480
2012
-
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening
New England Journal of Medicine, Vol. 366, Núm. 8, pp. 697-706
2010
-
Colorectal cancer prognosis twenty years later
World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867
2007
-
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants
American Journal of Gastroenterology, Vol. 102, Núm. 3, pp. 507-515
-
Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer
Gut, Vol. 56, Núm. 12, pp. 1714-1718
2004
-
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe
Helicobacter, Vol. 9, Núm. 3, pp. 249-254